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Corrosion of metal in biomedical devices could cause serious health problems to patients. Currently
ceramics coating materials used in metal implants can reduce corrosion to some extent with limitations.
Here we proposed graphene as a biocompatible protective film for metal potentially for biomedical
application. We confirmed graphene effectively inhibits Cu surface from corrosion in different biological
aqueous environments. Results from cell viability tests suggested that graphene greatly eliminates the
toxicity of Cu by inhibiting corrosion and reducing the concentration of Cu21 ions produced. We
demonstrated that additional thiol derivatives assembled on graphene coated Cu surface can prominently
enhance durability of sole graphene protection limited by the defects in graphene film. We also
demonstrated that graphene coating reduced the immune response to metal in a clinical setting for the first
time through the lymphocyte transformation test. Finally, an animal experiment showed the effective
protection of graphene to Cu under in vivo condition. Our results open up the potential for using graphene
coating to protect metal surface in biomedical application.
D
ue to their strength and excellent resistance to fatigue degradation, metals are extensively used in medical
fields such as bone and joint replacements1–3, stents4,5, dental materials6,7 and pacemaker cases or gen-
erators8,9. For instance, stainless steels, pure titanium and titanium alloys, and cobalt-base alloys are the
most common orthopaedic materials for total joint prostheses articulating with a plastic bearing surface for hips,
knees, shoulders, ankles, and many others10,11. In addition, dental amalgam alloys including mercury, silver, tin,
and copper, and sometimes zinc, palladium, indium, selenium and recently titanium have been in use for
restoring chewing surfaces12,13. Despite of numerous successes, the main disadvantage of most metals or metal
alloys used inmedicine is that they corrode due to chemical reactionswith the body enzymes and acids. It has been
demonstrated by N. J. Hallab et al. that soluble metal ions produced during corrosion induces an innate mono-
cytes/macrophage response and thus triggers immune responses, causing toxic, inflammatory and allergic or
mutagenic reactions to patients14. Corrosion can also generate metallic debris, including metal particles and
inorganic or organometallic compounds, which can deposit into the periprosthetic soft tissues to cause metal-
losis15. In addition to these adverse biological reactions, the corrosion process also degrades the structural
integrity of metal devices, resulting in premature structural failure or loosening16. Therefore, how to protect
metals from corrosion under physiological environment is a critical issue to be addressed for the sustainable
biomedical application of metals.
Corrosion is a gradual destruction of materials caused by various interactions between the materials and the
environment. Specifically, biological corrosion occurring in complex aqueous environment is mainly due to
electrochemical processes. The basic underlying reaction during biological corrosion is that, when contacting
to biological environment, metals are oxidized through electrochemical reactions to form ions, which then may
result in formation of soluble or insoluble metallic products or migrating away from the metal surface as free
ions17. To inhibit the corrosion process, protective coatings can be used to isolate metals from the environment,
such as body fluids. For example, zirconia ceramic surface transited from zirconium alloy is able to greatly
minimize corrosion and has been used in knee implants since 200118–20. However, it deteriorates and roughens
as it ages. A group of nanodiamond coating, including diamond-carbon coating and apatite-nanodiamond
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composite coatings21,22, recently has been proposed to hinder cor-
rosion for metal implants. However, noticeable permeability and
rough coating surface deteriorate their performance.
Recent advances in graphene research open up its great potential
in suppressingmetal corrosion in biological systems. Graphene, a flat
atomic monolayer composed of sp2-bonded carbon atoms, has been
shown as a promising biocompatible scaffold23. Additionally, gra-
phene is chemically inert and impermeable to gases even helium24,25.
J. Cho et al. and J. Park, R. S. Ruoff et al. have demonstrated that
graphene can provide effective oxidation resistance for the under-
lying Cu and Cu/Ni alloys25,26. Large scale synthesis of high quality
and uniform graphene films could be achieved through chemical
vapor deposition (CVD) method27. All these remarkable character-
istics enable graphene to be considered as an excellent protective
coating candidate for metals. K. I. Bolotin et al. and N. Birbilis
et al. have demonstrated that graphene films could serve as cor-
rosion-inhibiting coatings and have studied the passivation mech-
anism using electrochemical techniques28,29, respectively. Recently, F.
Alexis and A. Rao et al. have reported that graphene coating could
enhance both bio- and hemo-compatibility of implant materials30,31.
Notably, it has been found that in F. Alexis andA. Rao’s study, almost
all the cell viability results with the presence of graphene coated NiTi
were compatible or even lower than those observed for pristine NiTi,
indicating a modest protection offered by graphene to NiTi if there
was any. In this work, we demonstrate the potential of graphene as a
biocompatible protection film in vitro and, for the first time, in vivo.
In our work, we chose Cu, a less biocompatible metal than NiTi,
partially because it is the catalyst for graphene synthesis, more
importantly, it is one of the most toxic heavy metals32, therefore it
can offer a more sensitive system for cell viability and metal sensitiv-
ity tests. In addition to cell viability experiment, we carried out for the
first time lymphocyte transformation test (LTT), a standard clinical
test, to demonstrate that graphene coating can reduce immune res-
ponse. More significantly, we performed the first in vivo experiments
studying protection of Cu by graphene in live animals to evaluate the
potential of using graphene as a biocompatible passivated coating for
metals in physiological conditions. Chemically, we explored a new
strategy to utilize additional thiol derivatives self-assembled onmetal
surface to effectively enhance the durability of graphene protection.
Our results indicated graphene coating could successfully protect
metals and inhibit their corrosion in biological environments.
Results
Single layer graphene (SLG) used in this study was grown on 25 mm
thick Cu foils using chemical vapor deposition (CVD) conducted
under atmospheric pressure as previously reported33. Graphene
was expected to be synthesized on both sides of the Cu foils.
The protection effect of graphene on Cu foils in the aqueous
environment was first confirmed through monitoring corrosion of
Cu chemically. The corrosion of as-synthesized SLG coated Cu foils
(labeled ‘‘SLG/Cu’’) and bare Cu foils (labeled ‘‘Cu’’) in phosphate
buffered saline (PBS), fetal bovine serum (FBS), hank’s balanced salt
solution (HBSS), and cell culture media were tested. Corrosion of Cu
was monitored through measuring the concentrations of Cu21 ions,
the primarily corrosion products generated by the reaction of Cu
with these solutions34, using inductively coupled plasma-mass spec-
trometry (ICP-MS) on day 1, 2, 3, 4 and 5. All samples weremeasured
in triplicate. Results are shown in Fig. 1.
For all solutions tested, ICP-MS results clearly confirmed that
concentrations of Cu21 ions obtained for SLG protected Cu samples
(black) were always lower than those of bare Cu samples (blue) at all
time periods measured. Over time, Cu21 ion concentrations mea-
sured for SLG/Cu and Cu samples both increased as a cumulative
result of the corrosion. Additionally, variation in Cu21 ion concen-
trations measured from the bare Cu samples for these solutions
indicated different etching ability of the solutions, with cell culture
media as the most corrosive one and HBSS the weakest one. Besides,
in FBS, HBSS and media, graphene coating in SLG/Cu substantially
Figure 1 | Concentration of Cu21 ions from different biological solutions. Concentrations of Cu21 ions in (a) PBS, (b) FBS, (c) HBSS solutions and (d)
cell culture media with presence of SLG/Cu (black), BLG/Cu (red) and Cu (Blue) and blank solutions as controls (Pink) measured by ICP-MS,
respectively. All results are presented in a mass ratio (ppm).
www.nature.com/scientificreports
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reduced the concentrations of Cu21 ions compared to the corres-
ponding concentration from bare Cu. Distinctively, in PBS, Cu21
ion concentration measured from SLG/Cu seemed much closer to
that measured from the bare Cu samples. We attributed this result to
the formation of low soluble copper phosphate in PBS. Passivation of
copper phosphate precipitates on the bare Cu surface effectively
inhibited further etching of Cu, resulting in an apparent smaller
Cu21 ion concentration detected for bare Cu samples. At last, Cu21
ions detected in the control (pink) were approximately zero, consist-
ent with the composition of these biological solutions. Collectively,
slower and less corrosion of Cu observed with the coating of gra-
phene suggests that SLG successfully protects underlying Cu foils
and hinder corrosion in these solutions.
We further tested the protection of bilayer graphene (BLG) with
initial hypothesis that BLG potentially offers better protection based
on additional graphene coverage on Cu surface. As-synthesized
high-quality BLG coated Cu (labeled ‘‘BLG/Cu’’), with over 99%
bilayer coverage and a low defect density comparable to SLG35,
was used. Fig. 1 shows that for all solutions the Cu21 ion concen-
tration detected in the solution with BLG/Cu samples was lower
than that of bare Cu sample over the testing periods as expected.
Interestingly, the Cu21 ion concentrations for BLG/Cu sample were
found to be higher compared to those for the SLG/Cu sample in all
solutions despite the fact that more carbon coverage offered by BLG.
This result might be explained by stronger adhesion of SLG to Cu
surface than that of BLG, benefiting from the better ability of SLG
to adapt to the topography of the surface as a result of its flexibility,
as indicated by J. S. Bunch et al36. BLG with weaker adhesion to
Cu surface showed noticeably weaker protection effect compared
with the SLG case. Collectively, our chemical experiments in
different biological solutions confirmed that SLG and BLG coatings
both inhibit the corrosion of Cu surface underlying, resulting in
reduced concentration of Cu21 ions, substantial amount of which
could be fatal to cells. Impact of metal protection of SLG/Cu and
BLG/Cu were then further evaluated in the following in vitro cell
experiment.
MG-63 human bone cell line (American Type Culture Collection,
ATCC, Rockville, MD, USA) was chosen for in vitro experiments, for
its relevance when considering potential applications of graphene in
metal joint implants. Despite the dose dependent in vitro toxicity of
pristine graphene reported, graphene as a substrate has demon-
strated to be favorable for the adhesion, proliferation, and differenti-
ation of certain stem cells32. In our work, we first evaluated the effect
of graphene as a substrate to MG-63 cell growth by testing cell viab-
ility of cultured MG-63 cells on SLG coated glass substrates in com-
parison to cell cultures on bare glass substrates. We found no
differences in viability and cell morphology (See Supplementary
Fig. S2). The negligible effect of graphene substrates for cell viability
or cell growth was also observed by us in HeLa cell cultures prev-
iously. These results suggest that graphene is biocompatible when
being considered for a protection film in biomedical application.
To evaluate the protection effect of graphene, we performed cell
viability tests using graphene coated Cu as a toxic source in the MG-
63 cell culture. After seeding cell suspension in cell culture plates,
sterilized SLG/Cu, BLG/Cu foils and Cu foil with the identical sizes
were added to individual wells. A regular culture in a well untreated
with any foils was used as the control. Cellular experiments for each
sample were conducted in triplicate. After incubation for 1 day, A
metabolic activity assay, 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl-
tetrazolium bromide (MTT) was performed to assess the cell viability
of each well. Cell viability data was normalized to what is measured
for the control. Testing the cytotoxicity of Cu21 ions intentionally
delivered into cells was not in the scope of this study. A typical set of
results is illustrated in Fig. 2. After incubation for 1 day the well with
SLG/Cu sample shows 100.4% 6 2.2% cell viability, identical to the
control, and the cell viability measured for the BLG/Cu sample is
97.6%6 2.8%. In contrast, the cell viability for the well with Cu foil is
approximately zero.
To confirm that such greatly improved cell viability is a result of
inhibition of corrosion, we carried out ICP-MS measurements to
detect the ion concentration inmedium from eachwell. Fig. 3a shows
Cu21 ion concentrations measured from different sample wells. The
highest to lowest concentrations were detected from medium in cell
cultures with Cu (162.3 6 25.8 ppm), BLG/Cu (22.1 6 2.2 ppm),
SLG/Cu (6.9 6 0.3 ppm) and the control (0.6 6 0.0 ppm), directly
correlated to the lowest to highest cell viability detected from Cu,
BLG/Cu, SLG/Cu and control samples (Fig. 2), respectively. Notably,
despite that Cu21 ion concentration inside the cells might be distinct
from the concentration in the medium, fewer cells are expected to
survive when exposed to higher concentration of Cu21 ions.
Additionally, the ionic concentration obtained from BLG/Cu culture
is slightly larger than that from SLG/Cu culture, which is consistent
with results of cell viability (Fig. 2) and chemical experiments (Fig. 1).
We also characterized the morphology of all sample surfaces used
in the cellular experiments to directly visualize the impact of cor-
rosion to the metal surface. Scanning Electron Microscopy (SEM)
images in Fig. 3b exhibit surface morphology of SLG/Cu, BLG/Cu
and Cu before and after incubation. Before incubation surfaces for all
three samples were smooth. Contrast observed in images taken from
as-synthesized SLG/Cu and BLG/Cu indicates defects of the gra-
phene film and the exposed grain of the Cu foil. After incubation
of 1 day, the surface of bare Cu became extremely rough due to the
strong etching ability of medium to Cu. For both SLG and BLG
surface, a noticeable graphene film remains on the surface after
incubation (also See Supplementary Fig. S3). The surface of the Cu
foil protected by graphene become rougher yet still much smoother
compared to the bare Cu case.
In order to understand the durability of graphene protection, cell
viability experiments were carried out with incubation time up to 4
days, which is longest incubation time limited by the life of the
medium for the cell culture. Relative cell viability over 4 days is
shown in Fig. 4a for each sample. Zero cell viability was again
observed when the cell culture was exposed to bare Cu foil starting
as early as 1 day. In the first two days, coating of SLG and BLG both
successfully improved the cell viability compared to bare Cu foil,
consistent with results shown in Fig. 2. Significantly, a substantial
decrease in cell viability was observed at day 4 for both graphene
coated samples, suggesting the cell viability is not linearly correlated
to the exposure time period to Cu at day 4. Previous biometal toxi-
city studies have reported that the cell viability can decrease
exponentially under the following scenarios. First, for the case of a
constant ion concentration present in the medium incubation time
exceeds a threshold exposure time, and second, for the case of a fixed
incubation time considered the ion concentration exceeds a thresh-
Figure 2 | Relative cell viability of bone cells incubated with SLG/Cu,
BLG/Cu and bare Cu foil for 1 day. Control is the regular cell culture
without presence of any Cu foil.
www.nature.com/scientificreports
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old concentration, often in the range of 1 ppm to 100 ppm for
Cu34,37,38. The non-linear decrease when incubation time was 3–4
days observed in our study is a result of increasing Cu21 ion concen-
tration over time, which is consistent with previous biometal studies.
We also measured the ion concentration in the media from cell
cultures over time (Fig. 4b) and confirmed an increase in the ion
concentration over time, directly correlated to the trend of cell viab-
ility for SLG/Cu and BLG/Cu samples. Significantly, increase in con-
centration of Cu21 ion for SLG/Cu is reasonably linear (Fig. 4b),
indicating that the non-linear decrease of cell viability observed from
Fig. 4a cannot be attributed to the degradation of graphene.
Noticeably, the concentration of Cu21 ions for bare Cu measured
in themedium from cell cultures (blue in Fig. 4b) is found to increase
non-linearly with time, while Cu21 ion concentrationmeasured from
themediumwithout presence of cells shows a linear increase over the
same incubation period (Fig. 1d). This difference could be probably
attributed to that for a relatively long incubation time, in this case, 3–
4 days, an acidification induced by a sufficient amount of dead
cells39,40 accelerates etching rate of Cu with presence of the cell cul-
ture, resulting in a higher Cu21 ion concentration.
Ideally, a defect-free graphene can potentially offer effective long
term protection by eliminating Cu21 ion concentration. When
defects exist, the corrosive solution diffuses through cracks of gra-
phene resulting in local etching of Cu foil which are not only limited
to the defects but may also progresses underneath the graphene
film41. Overtime, the accumulative ion concentration exceeds toxicity
limit and triggers the exponential decrease in cell viability. In this
study, we explored the possibility of using metal surface functiona-
lization to achieve more enduring protection42,43. Here, we chose 1-
Decanethiol to form self-assembly monolayer on Cu foil. Aliphatic
thiols are specifically toxic to erythrocytes, and the toxicity decreases
with increased chain length44, so 1-Decanethiol with long chain
length presents minimal cytotoxicity to bone cells used here. We
expected that monolayer of 1-Decanethiol self-assembled on
exposed Cu where graphene defects locate slows down the diffusion
rate of medium because of hydrophobicity of alkyl chain and there-
fore improves protection.
As-synthesized SLG/Cu was cleaned and treated with ethanolic
solution of the thiol45 (labeled as ‘‘SLG/Cu-SH’’). A piece of bare Cu
foil with the identical size was also treated with thiol modification
(labeled ‘‘Cu-SH’’). Both SLG/Cu-SH and Cu-SH as well as unmodi-
fied SLG/Cu from the same growth batch, bare Cu were used for
cellular experiments. After incubation for 3 days, MTT assay was
performed to assess the cell viability. Results are showed in Fig. 5.
Compared to SLG/Cu, SLG/Cu-SH with thiol group protection
exhibited improved cell viability from 26.5% 6 9.4% to 55.8% 6
8.4% at incubation of 3 days, while thiol coating in Cu-SH improved
the viability to 1.9% 6 0.5% compared to the 0.5% 6 1.5% viability
observed for bare Cu. Collectively, results suggested that SLG on Cu
foil was the major factor for protection, and combined with addi-
tional thiol coating it offers an enhanced protection in a longer
incubation period.
To extend the application of graphene coating, we also tested the
performance of mechanically transferred graphene for inhibiting
corrosion of metal surface. To establish a meaningful comparison
between protections by as-grown graphene on Cu substrate and by
transferred graphene on the same metal, SLG grown on Cu foil was
Figure 3 | Concentration of Cu ions and SEM images of Cu foils after
incubation for 1 day. (a) Concentrations of Cu21 ions of control medium,
and of medium after incubated with SLG/Cu, BLG/Cu and Cu for 1 day.
(b) SEM images of SLG/Cu, BLG/Cu and Cu before and after incubation.
Insets are high magnification SEM images for SLG/Cu and BLG/Cu after
incubation, respectively. Scale bar: 1 mm.
Figure 4 | Relative cell viability and concentration of Cu21 ions as a function of time. (a) Relative cell viability vs. time for SLG/Cu, BLG/Cu and Cu
samples; (b) Concentration of Cu21 ions in cell culture medium after incubation with SLG/Cu. BLG/Cu and Cu samples calculated from ICP-MS.
Medium taken from a regular cell culture without presence of any Cu foils is used as the control.
www.nature.com/scientificreports
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transferred to another bare Cu foil (labeled ‘‘Tr-SLG/Cu’’) following
the typical transferring procedure reported28,33,35. Additional thiol
coating was also performed to the transferred sample (labeled ‘‘Tr-
SLG/Cu-SH’’) using the same strategy discussed above. Together
with Cu and Cu-SH, Tr-SLG/Cu and Tr-SLG/Cu-SH were tested
for cellular experiments. As shown in Fig. 6, cell viability obtained
after 1 day incubation for the Tr-SLG/Cu sample is found to be 6.4%
6 3.9%, comparable with that obtained from Cu-SH and Cu, which
is likely a result of tears and rips in the graphene film produced
during its transfer28. Transferred graphene, combined with addi-
tional thiol coating, offers reasonably well protection for Cu cor-
rosion, resulting in 61.1% 6 6.2% viability. These results suggested
that although it provides limited protection, transferred SLG
together with additional metal surface functionalization with thiol
is possible to be considered as a universal protection film preventing
metal corrosion in chemical, biological and medical applications.
To demonstrate that the effective protection offered by graphene
coating for metal from corrosion further reduces the immune res-
ponse of patients to metal potentially in biomedical application, we
conducted the lymphocyte transformation test (LTT) with SLG
coated Cu, bare Cu, Cu21 ion solution in medium and standard
negative and positive controls. LTT measures the proliferation of
lymphocytes as a measure of immune response when lymphocytes
have been exposed to potential toxic agents. It is the standard test
proposed by the International Union of Immunological Societies to
detect patient’s immune response to metal and commonly per-
formed in the clinic setting before metal implant procedures46–48.
In our work, LTT tests were performed for SLG/Cu and bare Cu
samples. 6.6 3 1023 mM Cu21 ion solution in media was tested as a
positive control considering Cu21 ion as a toxic source activating
lymphocytes. Combination of Phorbol-12-Myristate-13-Acetate
(PMA) (25 ng/ml) and ionomycin (2.5 mg/ml) stimulating lympho-
cytes proliferation were used as another standard positive control.
Untreated wells with lymphocytes culture were used as negative
controls49. The proliferations of lymphocytes for all samples were
quantified by MTT50. Stimulation index (SI), defined as the ratio of
the absorbance of the sample detected inMTT tests to the absorbance
of the negative control, is a measure of the lymphocytes proliferation
and presented in Fig. 7. All samples were measured in triplicate.
Fig. 7 shows that the SIs for SLG/Cu samples were 0.99 6 0.02 and
0.95 6 0.01 after incubation for 1 day and 2 days, respectively,
indicating that SLG/Cu does not activate lymphocyte proliferation.
For bare Cu, after 1 day incubation the SI was 20.04 6 0.001, indi-
cating that all cells were dead. Previously J. J. Jacobs and co-workers
found that Cu21 ion decreased lymphocyte proliferation to a SI lower
than 0.5 at a concentration of 0.1 mM in the LTT experiment51. In
our case, the Cu21 ion concentration in the media for bare Cu
samples was measured to be approximately 130 ppm or 2 mM,
therefore a close to 0 SI found in our experiment was expected. It
has been suggested that lower concentrations than 0.1 mMwould be
appropriate for metal-reactivity testing of Cu using LTT. Here we
also chose a Cu21 ion solution in medium with 6.6 3 1023 mM for
comparison. After 1 day and 2 day incubations, the SI obtained from
the 6.6 3 1023 mM Cu21 ion solution was 1.01 6 0.01 and 1.50 6
0.03, respectively, clearly indicating activation of lymphocytes.
Lastly, the lymphocytes showed expected proliferation responses to
PMA/Ionomycin, the standard positive control. The SIs measured
were 1.76 6 0.07 and 3.77 6 0.45 for 1 day and 2 day incubations,
respectively. Collectively, the LTT results, specifically the compar-
ison of results from SLG coated Cu, Cu and 6.63 1023 mMCu21 ion
solution, demonstrated that protection effect of graphene preventing
metal corrosion can substantially reduce immune response in a bio-
logical environment, opening potential to use graphene coating to
improve metal devices for biomedical application.
At last, we performed an animal experiment to test the effect of
graphene protection in vivo by surgically implanting graphene
coated Cu foils and bare Cu foils into rats, respectively. Blood were
extracted from implanted rats and the concentrations of Cu21 ions
were analyzed using ICP-MS. Blood samples from rats before
implantation were used as control. Results, shown in Fig. 8, demon-
strated the following key features. First, concentrations of Cu21 ions
in blood from rats with implanted SLG/Cu and bare Cu were both
observed to increase with time. Second, we noticed that within 1 day
Figure 5 | Relative cell viability data of bone cells incubated with SLG/Cu,
SLG/Cu-SH, Cu-SH and bare Cu foil for 3 days. Control is a regular
cell culture without presence of any Cu samples.
Figure 6 | Relative cell viability of bone cells incubated with Tr-SLG/Cu,
bare Cu, Tr-SLG/Cu-SH, and Cu-SH for 1 day incubation. Control is a
regular cell culture without presence of any Cu sample.
Figure 7 | Stimulation index for lymphocyte. After incubating with SLG/
Cu (black), Cu foil (red), Cu21 ions (blue) and PMA/Ionomycin (violet)
for 1 day and 2 days.
www.nature.com/scientificreports
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after implantation, the concentrations of Cu21 ions in blood of rats
with SLG/Cu foils were close to those of control, while even just at
6 h after implantation, the concentrations of Cu21 ions from rats
with implanted bare Cu foils appeared to be more than 1.5 times of
those of control. More significantly, the concentration of Cu21 ions
from rats with bare Cu foil were always detected to be higher than
those from rats with SLG/Cu foils during the whole course up to 17
days after implantation. In summary, our results clearly demon-
strated the protection effect of SLG can effectively inhibit corrosion
of Cu therefore decrease concentration of Cu21 ions under in vivo
condition. It has been well studied that accumulated Cu21 ions in
blood results in undesirable biological effects, such as reducing organ
function or leading to early death52,53. Further investigation on
impact of graphene protection on these adverse effects in vivo is
needed.
Discussion
In summary, we explored the possibility of using graphene as a
protective layer to inhibit corrosion of Cu foils in biological envir-
onment. Both chemical experiments and cellular experiments
showed that SLG and BLG protection could both greatly minimize
the concentration of Cu21 ions, and therefore graphene coating
substantially decrease the toxicity of Cu surface to bone cells, par-
ticularly in 1–2 day testing period. However, cumulatively increased
ion concentration resulted from defects of graphene will trigger an
exponential decrease in cell viability at day 3 and 4, which deteri-
orate enduring protection of graphene. Additional surface functio-
nalization of thiol derivatives on graphene coated Cu foil has
potential to significantly improve the durability of protection by
hindering diffusion of medium through defects of graphene.
Transferred graphene sheet offers reasonable protection when thiol
functionalization was introduced. The LTT results indicate the gra-
phene coating inhibits metallic allergic immune response. The ani-
mal study shows the graphene film can also provide effective
protection to metals under in vivo condition. Our work demon-
strated graphene coating could be used as a possible versatile strat-
egy to protect metals under physiological conditions, opening up
potentials for its biomedical application such as metal implants. For
practical application of graphene in metal implants, as grown gra-
phene on metals other than Cu needs to be developed and evaluated.
Alternatively, further functionalization of graphene or metal might
be possible to increase the interaction between graphene and Cu foil
surface therefore enhance the protection of transferred graphene.
Methods
Graphene synthesis. SLG samples were grown on 25 mm thick of Cu foils (Sigma-
Aldrich, 99.98%) by CVD at ambient pressure. The Cu foil was loaded into a CVD
furnace and heated to 1000uC in 50 sccm of flowing H2. After 1000uC was attainted,
the foil was annealed for 1 hour. Then 10 sccm CH4 was flowed for 30 min. The
system was then cooled to room temperature.
To prepared BLG samples, the system was purged with argon gas and evacuated to
a vacuum of 0.1 Torr after loading Cu foil into furnace. The foil was then heated to
1000uC in 100 sccm H2 environment at 0.35 Torr. When 1000uC was reached,
70 sccm of CH4 was flowed for 15 min at 0.45 Torr. The sample was then cooled
slowly to room temperature at a rate of 18uC/min. The pressure was maintained at
0.5 Torr with 100 sccm of argon flowing during cooling.
Raman spectroscopy was performed on graphene transferred on SiO2/Si substrates
with laser excitation wavelength of 514 nm. The spectra (See supplementary Fig. S1)
showed single-layer and bilayer features for SLG and BLG, respectively.
Chemical experiment. As-synthesized SLG/Cu, BLG/Cu and bare Cu with the
identical size of 1.2 cm3 1.2 cmwere cleanedwith acetone and isopropanol and then
immersed in 3 ml of different biological solutions, including PBS, FBS, HBSS and cell
culture media. Solutions without the presence of Cu were used as the control for each
group receptively. All samples were placed in an oven at 37uC. For FBS, HBSS and cell
media samples, 200 ml of solution was taken and diluted with ultra-pure water and
70% nitric acid (VWR, Aristar Ultra) to 10 ml. For PBS samples, due to precipitation
of insoluble copper phosphate, sample solutions were first sonicated to get uniform
suspension, and then 200 ml of the suspension were taken and diluted with ultrapure
water and 70% nitric acid to 10 ml. All diluted solutions were allowed to statically
stand for 24 hours to achieve homogenous solutions. Afterwards, 200 ml of the
diluted solutionwas further diluted with 2%nitric acid to 10 ml, and then analyzed by
ICP-MS. A Cu21 ion solution of 10 ppb weight to weight ratio was used as the
standard.
Cellular experiment. MG-63 human bone cell line (American Type Culture
Collection, ATCC, Rockville, MD, USA) was used. In a typical experiment, 3 ml of
cell suspension with density of 1 3 105 cells/ml were added into each well of a 6-well
plate, and first incubated with A TCC-formulated Eagle’s Minimum Essential
Medium for 4 hours allowing cells to adhere to the bottom of the well. Then sterilized
SLG/Cu, BLG/Cu foils and Cu foil with the identical sizes were added to individual
wells. A regular culture in a well untreated with any foils was used as the control. The
plate was then transferred into an incubator at 37uC with a humidified atmosphere
containing 5% CO2. After incubation for 1 day, the cell culture medium and all Cu
foils were gently removed from wells and wells were washed twice with 1 ml PBS
solution. Then a metabolic activity assay, 3-(4, 5-dimethylthiazol-2-yl)-2, 5-
diphenyltetrazolium bromide (MTT) was performed to assess the cell viability of each
well. Cell viability data was normalized to what is measured for the control. 200 ml of
cell culture medium removed from wells before MTT tests was used for ICP-MS
measurement. For long term incubation, instead of changingmedia every other day30,
we kept the same media in each well during the cell viability experiment, considering
the cytotoxicity of metals mainly relies on accumulated concentration of metal ions.
Maintaining media over the test course offered a more meaningful result to evaluate
graphene protection.
Thiol functionalization. As-synthesized SLG/Cu was quickly treated with
hydrochloric acid to remove oxide layer, then rinsed with ultrapure water to remove
residual impurities. After being dried in nitrogen, the SLG/Cu foil was immediately
immersed in a 7.5 mM ethanolic solution of the thiol. After 2 h in the thiol solution
the sample (labeled ‘‘SLG/Cu-SH’’) was copiously rinsed with ethanol to remove the
physisorbed material and finally dried with nitrogen.
Graphene transfer. To transfer graphene to another substrate, one side of the as-
synthesized SLG was coated with PMMA (Microchem) resist and cured at 180uC for
1 min. The other side of the sample was exposed toO2 plasma to remove the graphene
on that side. The sample was then left in Ammonium persulfate (VWR, 98%) solution
for overnight to completely dissolve away the copper layer. Then the graphene was
transferred to one side of a Cu foil with almost the same size. The process was repeated
to transfer another piece of graphene to the other side of the Cu foil. The PMMA
coating was removed with acetone and isopropanol. Finally, the Cu foil was rinsed
with deionized water several times.
Lymphocyte transformation test. Mouse spleen tissues were collected aseptically
and subsequently transferred to a sterile Petri dish containing medium. The spleen
tissues were then grounded to release cells to medium. After centrifuging the cell
suspension, the supernate was removed, and the precipitate was treated with
Ammonium-Chloride-Potassium (ACK) for a few minutes to lyse the present red
blood cells. Then PBS was added and the solution was centrifuged again to collect the
lymphocyte precipitate. Lymphocytes suspension with a density of 5 3 106 cells/ml
was then prepared by mixing the lymphocyte precipitate with RPMI 1640 medium.
3 ml of the lymphocytes suspension were added into each well of a 6-well plate. Then
1.0 cm3 1.0 cm SLG/Cu and bare Cu foils were added into wells respectively. To test
the toxic effect of Cu21 ion, 10 ml of Cu21 ion solution inmedia was added to each new
well with 3 ml of the lymphocyte suspension to get final ion concentration of 6.6 3
1023 mM as a toxic source for T-cell activation. As the standard positive control,
PMA (25 ng/ml) and ionomycin (2.5 mg/ml) were used to stimulate cell proliferation
Figure 8 | Concentrations of Cu21 ions in blood extracted from live rats.
Concentrations of Cu21 ions from normal rats before implantation as
control (black square), rats with implanted SLG/Cu foils (blue triangles)
and rats with implanted Cu foils (red dots) as a function of time after
implantation.
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as a means of comparison for other wells. Untreated wells were used as negative
control. Each sample treatment was conducted in triplicate. After incubation for 1 day
or 2 days in a humidified CO2 incubator at 37uC, MTT tests were conducted to
measure the number of lymphocytes.
In vivo experiment. The protocol was approved by the Purdue University Animal
Care and Use Committee, and was performed in accordance with guidelines. Adult
female Long-Evans rats (,300 g) were anesthetized by 90 mg/kg ketamine and
5 mg/kg xylazine. Skin and muscle was surgically opened by layer at T10 spine. After
the exposure of spine, a piece of graphene coated Cu foil with size of 0.5 cm3 1.3 cm
was implanted into the rat by the left side of the spine. Then themuscles and skin were
closed in layers, and the rat was placed on a heating pad to maintain its body
temperature until it awoke. The procedure was performed on three rats. A piece of
bare Cu foil with the identical size was implanted into other three rats for comparison
following the same procedure (Fig. S4 in supplementary information), The analgestic
buprenorphine (0.05–0.10 mg/kg) was administered every 12 h through
subcutaneous injection for the first 3 days post-surgery for post-operation pain
management. Tomonitor concentration of Cu21 ions, blood was extracted via jugular
vein at 6 h, 12 h, 24 h, and up to 17 days after the implantation for ICP-MS analysis.
Blood extracted from rats before the implantation procedure was used as control.
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